Large Italian Multicenter Study on Prognostic Value of Baselines Variables in mCRPC Patients Treated with ²²³RaCl₂: Ten Years of Clinical Experience

<b>Background/Objectives:</b> The prognostic value of baseline clinical parameters in predicting the survival prolonging effect of Radium-223-dichloride (²²³RaCl₂) for metastatic castration resistant prostate cancer (mCRPC) patients has been the object of intensive research and...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Maria Silvia De Feo, Luca Filippi, Matteo Bauckneht, Elisa Lodi Rizzini, Cristina Ferrari, Valentina Lavelli, Andrea Marongiu, Gianmario Sambuceti, Claudia Battisti, Antonio Mura, Giuseppe Fornarini, Sara Elena Rebuzzi, Alessio Farcomeni, Alessandra Murabito, Susanna Nuvoli, Miriam Conte, Melissa Montebello, Renato Patrizio Costa, Arber Golemi, Manlio Mascia, Laura Travascio, Fabio Monari, Giuseppe Rubini, Angela Spanu, Giuseppe De Vincentis, Viviana Frantellizzi
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2025-01-01
Edice:	Diagnostics
Témata:	Radium-223 mCRPC prostate cancer multicenter study radionuclide therapy
On-line přístup:	https://www.mdpi.com/2075-4418/15/3/339
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!